[1] The peptide won't appear to have an impact on levels of insulin or IGF1 in studies Up to now; consequently, it does not appear to trigger diabetes development or induce glucose intolerance in exam designs, nevertheless additional studies are needed to examine this facet.[2]The efficacy of topical AOD 9604 formulations remains to be a issue of i